Thrivent Financial For Lutherans Xenon Pharmaceuticals Inc. Transaction History
Thrivent Financial For Lutherans
- $28.6 Billion
- Q1 2025
A detailed history of Thrivent Financial For Lutherans transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 30,699 shares of XENE stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,699
Previous 30,699
-0.0%
Holding current value
$1.02 Million
Previous $1.2 Million
14.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$191 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$152 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$126 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$111 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$103 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.07B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...